Moderna was last year’s third-best-performing stock in the S&P—it’s now this year’s worst.
Moderna Stock Crash Intensifies: Losses Top $130 Billion After Scientists Find Covid Boosters Aren’t Halting Omicron Infections
Moderna was last year’s third-best-performing stock in the S&P—it’s now this year’s worst.